Puehler T, Haneya A, Philipp A, Camboni D, Hirt S, Zink W, Lehle K, Rupprecht L, Kobuch R, Diez C, Schmid C
Department of Cardiothoracic Surgery, Medical Center University Regensburg, Regensburg, Germany.
Thorac Cardiovasc Surg. 2010 Jun;58(4):204-9. doi: 10.1055/s-0029-1241028. Epub 2010 May 31.
Minimized extracorporeal circulation (MECC) is a promising alternative to standard extracorporeal circulation (ECC) and its use is increasing in routine coronary bypass surgery. We analyzed the clinical outcome of patients with reduced left ventricular function who underwent coronary artery bypass surgery with MECC or with standard ECC.
From January 2003 to September 2008, 238 patients with a left ventricular function < 30 % underwent bypass surgery with ECC or MECC. The primary end point of our retrospective observational study was 30-day mortality. Secondary endpoints were the transfusion requirements, as well as intensive care and the in-hospital course.
Demographic data, comorbidities and left ventricular function were similar in the study groups. MECC patients had a tendency towards a lower 30-day mortality rate, a better postoperative renal function and reduced ventilation times. Extracorporeal circulation time and postoperative high-dose inotropic support were significantly lower in the MECC group, while the stays in the intensive care unit and in hospital were comparable between the two groups. In our study, age in the ECC group, and previous infarction and New York Heart Association grade IV in the MECC group were preoperative risk factors associated with a higher mortality.
Coronary bypass surgery using MECC is feasible and safe for patients with severely impaired left ventricular function. It is a promising alternative to ECC with a low mortality rate and a more favorable postoperative course.
微创体外循环(MECC)是标准体外循环(ECC)的一种有前景的替代方法,其在常规冠状动脉搭桥手术中的应用正在增加。我们分析了接受MECC或标准ECC冠状动脉搭桥手术的左心室功能降低患者的临床结局。
2003年1月至2008年9月,238例左心室功能<30%的患者接受了ECC或MECC搭桥手术。我们这项回顾性观察研究的主要终点是30天死亡率。次要终点是输血需求、重症监护情况及住院过程。
研究组间的人口统计学数据、合并症及左心室功能相似。MECC组患者30天死亡率有降低趋势,术后肾功能更好,通气时间缩短。MECC组的体外循环时间和术后高剂量血管活性药物支持显著更低,而两组在重症监护病房和住院的时间相当。在我们的研究中,ECC组患者的年龄、MECC组患者既往梗死史及纽约心脏协会IV级是与较高死亡率相关的术前危险因素。
对于左心室功能严重受损的患者,采用MECC进行冠状动脉搭桥手术是可行且安全的。它是ECC的一种有前景的替代方法,死亡率低,术后病程更有利。